Xeris Pharmaceuticals | XERS - Revenu Net

Prix De L'Action
5.85
Variation Quotidienne
-0.16 -2.66%
Mensuellement
2.09%
Annuel
40.63%
Q2 Prévisions
5.86




Revenu Net Changement Date
Celltrion KRW 331.35B 270.18B 2025-09
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD 19.97M 57.93M 2025-12
Ovoca Bio EUR -765K 4.89M 2025-06
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pharma Mar EUR 59.66M 63.76M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Sartorius EUR 43.8M 11.3M 2025-09
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 687.04M 244.51M 2025-09